Abstract
AbstractBring-your-own-device (BYOD) methods for collecting patient-reported outcome (PRO) data in clinical trials can decrease patient burden and improve data quality. However, adoption of BYOD in clinical trials is limited by the absence of publicly available case studies where BYOD PRO data supported regulatory medical product approvals. Anecdotally, we are aware of multiple examples where efficacy and safety label claims were based on BYOD PRO data; however—except for one—these examples have not been made public. The absence of these case studies can lead sponsors to be hesitant to use BYOD for capturing primary and secondary PRO-based endpoints in their trials. This commentary outlines the context of the issue faced and concludes with a call for sponsor transparency with regard to BYOD use through publicizing where approved labeling claims were based on BYOD data. We suggest how this data could be systematically captured going forward. Sharing this information will benefit the clinical trials enterprise by increasing confidence in the utilization of BYOD and provide opportunities to enhance patient-centricity.
Publisher
Springer Science and Business Media LLC
Subject
Pharmacology (medical),Public Health, Environmental and Occupational Health,Pharmacology, Toxicology and Pharmaceutics (miscellaneous)
Reference20 articles.
1. Basch E, Abernethy AP, Mullins CD, et al. Recommendations for incorporating patient-reported outcomes into clinical comparative effectiveness research in adult oncology. J Clin Oncol. 2012;30:4249–55.
2. Gnanasakthy A, Norcross L, Romano C, et al. A review of patient-reported outcome labeling of fda-approved new drugs (2016–2020): counts, categories, and comprehensibility. Value Health. 2021. https://doi.org/10.1016/j.jval.2021.10.006.
3. U.S. Food and Drug Administration. Patient-focused drug development: methods to identify what is important to patients guidance; 2019. https://www.fda.gov/media/131230/download. Accessed 1 Oct 2021
4. U.S. Food and Drug Administration. Patient-focused drug development: collecting comprehensive and representative input; 2020. https://www.fda.gov/media/139088/download. Accessed 1 Oct 2021
5. Gwaltney C, Coons SJ, O’Donohoe P, et al. “Bring Your Own Device” (BYOD): the future of field-based patient-reported outcome data collection in clinical trials? Ther Innov Regul Sci. 2015;49:783–91.